Valuation Biogen Inc. Xetra

Stocks

Market Closed - Xetra Other stock markets 11:35:46 2026-07-10 EDT			5-day change	1st Jan Change
173.22 ^EUR	-0.05%		-8.87%	+15.52%

07-08	Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says	MT
07-08	BofA Securities Adjusts Biogen Price Target to $217 From $203	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	35,242	39,877	37,495	22,283	25,818	29,402	-	-
Change	-	13.15%	-5.97%	-40.57%	15.86%	13.88%	-	-
Enterprise Value (EV) ¹	37,820	40,560	43,384	26,204	28,289	34,911	32,787	29,855
Change	-	7.24%	6.96%	-39.6%	7.96%	23.41%	-6.08%	-8.94%
P/E	23.1x	13.3x	32.5x	13.7x	20x	30.3x	16.7x	14.7x
PBR	3.26x	3.02x	2.53x	1.33x	1.42x	1.57x	1.42x	1.29x
PEG	-	0x	-0.5x	0.3x	-0.9x	-1.2x	0.2x	1.1x
Capitalization / Revenue	3.21x	3.92x	3.81x	2.3x	2.61x	2.92x	2.83x	2.75x
EV / Revenue	3.44x	3.99x	4.41x	2.71x	2.86x	3.47x	3.16x	2.8x
EV / EBITDA	9.13x	11.2x	14.3x	7.1x	7.82x	11x	9.19x	7.99x
EV / EBIT	10.3x	13.1x	17x	8.69x	9.97x	12.9x	10.2x	8.73x
EV / FCF	11.2x	35.5x	34.2x	9.63x	13.8x	13.1x	12.6x	12.4x
FCF Yield	8.94%	2.82%	2.93%	10.4%	7.25%	7.65%	7.95%	8.08%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	10.4	20.87	7.97	11.18	8.79	6.563	11.93	13.53
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	10,982	10,173	9,836	9,676	9,891	10,054	10,384	10,678
EBITDA ¹	4,144	3,618	3,040	3,689	3,618	3,182	3,570	3,736
EBIT ¹	3,656	3,099	2,545	3,015	2,838	2,716	3,200	3,418
Net income ¹	1,556	3,047	1,161	1,632	1,293	1,495	1,969	2,216
Net Debt ¹	2,578	683	5,888	3,921	2,471	5,509	3,385	452.9
Reference price ²	239.92	276.92	258.77	152.92	175.99	199.15	199.15	199.15
Nbr of stocks (in thousands)	146,893	144,001	144,898	145,719	146,702	147,637	-	-
Announcement Date	2/3/22	2/15/23	2/13/24	2/12/25	2/6/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REGENERON PHARMACEUTICALS, INC.	17.23x	3.77x	10.12x	0.59%	67.61B
UCB	25.62x	5.26x	15.43x	0.62%	51.6B
SAMSUNG BIOLOGICS CO.,LTD.	34.6x	11.72x	22.41x	-.--%	43B
CSL LIMITED	-46.01x	3.23x	9.56x	3.34%	40.94B
MODERNA, INC.	-7.88x	11.31x	-6.94x	-.--%	27.09B
INCYTE CORPORATION	37.89x	3.25x	9.81x	-.--%	23.32B
INNOVENT BIOLOGICS, INC.	62.11x	6.29x	41.57x	-.--%	19.89B
SWEDISH ORPHAN BIOVITRUM AB	26.16x	5.4x	14.45x	-.--%	16.91B
BRIDGEBIO PHARMA, INC.	-39.16x	18.25x	-55.41x	-.--%	16.84B
Average	12.29x	7.61x	6.78x	0.5%	34.13B
Weighted average by Cap.	12.31x	6.73x	9.81x	0.68%